-
1 week ago | 
juve.de | Konstanze Richter
Zugang zu allen digitalen JUVE Inhalten inklusive E-Paper aller Magazine Exklusiver Zugang zu allen Rankings, Datenanalysen und Hintergrundartikeln Inhouse-Teams erhalten kostenfreien Zugriff Themennewsletter JUVE Business Weekly und JUVE Tech Weekly Ihre Firma hat bereits ein JUVE+-Abo? Zum Login Wie zuvor für das Oberverwaltungsgericht wog für den 10. Senat das Gesetz gegen Wettbewerbsbeschränkungen (GWB) schwerer als das IFG (Az: 10 C 2.24).
-
1 week ago | 
juve-patent.com | Konstanze Richter
Full-service firm Taylor Wessing already has an IP team in the French capital focusing mainly on soft IP. The new dedicated patent team will launch with four litigators. Marina Jonon joins as counsel and Louise Millot as associate, both following Fabre from Pinsent Masons. Millot had moved to Pinsent Masons from August Debouzy just a year ago. A third associate, Clémence de Marassé-Enouf, will arrive from A&O Shearman in June.
-
1 week ago | 
juve.de | Konstanze Richter
Die 56-Jährige Volljuristin löst Volker Wissing ab, der seit Ausscheiden der FDP aus der Ampelkoalition im Herbst das Bundesjustizministerium kommissarisch neben dem Verkehrsministerium leitete. Hubig begann ihre Laufbahn 1996 als Staatsanwältin und später Richterin in Ingolstadt. 2000 wechselte sie als Referentin in das Bundesministerium der Justiz nach Berlin.
-
2 weeks ago | 
juve.de | Konstanze Richter
Zugang zu allen digitalen JUVE Inhalten inklusive E-Paper aller Magazine Exklusiver Zugang zu allen Rankings, Datenanalysen und Hintergrundartikeln Inhouse-Teams erhalten kostenfreien Zugriff Themennewsletter JUVE Business Weekly und JUVE Tech Weekly Ihre Firma hat bereits ein JUVE+-Abo? Zum Login Komoot hat sich seit seiner Gründung 2010 zu einer der führenden Outdoor-Plattformen in Europa entwickelt.
-
2 weeks ago | 
juve.de | Konstanze Richter
Zugang zu allen digitalen JUVE Inhalten inklusive E-Paper aller Magazine Exklusiver Zugang zu allen Rankings, Datenanalysen und Hintergrundartikeln Inhouse-Teams erhalten kostenfreien Zugriff Themennewsletter JUVE Business Weekly und JUVE Tech Weekly Ihre Firma hat bereits ein JUVE+-Abo? Zum Login Mit dem Kauf von SpringWorks Therapeutics wollen die Darmstädter ihre Unternehmenssparte Healthcare weiter ausbauen.
-
3 weeks ago | 
juve-patent.com | Konstanze Richter
AstraZeneca is defending its EP 1 506 211 against Glenmark, Teva and Generics UK (Viatris). The patent expired in May 2023. However, the British SPCs based on the patent are valid until May 2028. These are GB13/021 relating to active ingredient dapagliflozin and SPC GB14/050 relating to a combination of dapagliflozin and metformin. Dapagliflozin is an SGLT2 inhibitor which helps lower blood sugar levels and treats patients with type 2 diabetes.
-
3 weeks ago | 
juve-patent.com | Konstanze Richter
A spokeswoman for the Düsseldorf Regional Court confirmed to JUVE Patent that Sabine Klepsch, long-time presiding judge of Chamber 4c responsible for patent proceedings, is leaving the national court to work full-time at the UPC. Since the new court’s launch, she has worked part-time at the Hamburg local division as presiding judge alongside legally qualified judge Stefan Schilling.
-
3 weeks ago | 
juve-patent.com | Konstanze Richter
In September, the UPC’s Munich local division will consider whether NanoString is entitled to damages for the period it was barred from the market due to a preliminary injunction. The day before, the same division will hear the infringement case concerning the same patent. The panel will comprise presiding judge Matthias Zigann and judges Tobias Pichlmaier and András Kupecz. Writing UPC historyThe case was among the first major disputes at the UPC.
-
1 month ago | 
juve-patent.com | Konstanze Richter
The dispute centred on Novartis’ patent EP 2 501 384, which protects a method of treating proliferative disorders and other pathological conditions mediated by BCR-ABL, C-KIT, DDR1, DDR2 or PDGF-R kinase activity. In simpler terms, it protects the administration of nilotinib together with apple sauce. Nilotinib is an anti-cancer medication used to treat chronic myelogenous leukaemia (CML). Novartis is also researching its use in treating Alzheimer’s disease.
-
1 month ago | 
juve-patent.com | Konstanze Richter
The proceedings between Yellow Sphere and Knaus Tabbert related to EP 3 356 109 B1. They centred on the interpretation of product-by-process claims. EP 109 covers a new type of frame for campervans that is particularly light yet strong. Erwin Härtwich and Alexander Christ are listed as inventors in the EPO register. The former was plaintiff alongside Yellow Sphere. Yellow Sphere is a Cologne-based company that specialises in the development, registration and marketing of intellectual property rights.
